Krebs Biochemicals and Industries share news, announcements and annual reports
NSE: KREBSBIOBSE: 524518Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹57.93.
30 Oct: open ₹56.60, high ₹58.49, low ₹56.33
- Under NSE's long-term additional surveillance, stage I, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹122 Cr2,740th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −14.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- Net worth zero or below
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 5,397
Krebs Biochemicals and Industries board meetings
159 filed, newest first. Page 1 of 4.
Oct 2026
Jul 2026
Jun 2026
26 Jun · Board meeting
May 2026
Jan 2026
Nov 2025
4 Nov · Board meeting
Oct 2025
Jul 2025
May 2025
20 May · Board meeting
Feb 2025
4 Feb · Board meeting
Jan 2025
Nov 2024
11 Nov · Board meeting
Oct 2024
Aug 2024
7 Aug · Board meeting
Jul 2024
May 2024
21 May · Board meeting
8 May · Board meeting
Feb 2024
12 Feb · Board meeting
Jan 2024
17 Jan · Board meeting
Nov 2023
8 Nov · Board meeting
Oct 2023
Aug 2023
9 Aug · Board meeting
Jul 2023
21 Jul · Board meeting
May 2023
Feb 2023
3 Feb · Board meeting
3 Feb · Board meeting
Jan 2023
23 Jan · Board meeting
Nov 2022
Aug 2022
Jul 2022
May 2022
Feb 2022
12 Feb · Board meeting
Dec 2021
30 Dec · Board meeting
Nov 2021
9 Nov · Board meeting
Oct 2021
23 Oct · Board meeting
18 Oct · Board meeting
Jul 2021
30 Jul · Board meeting
22 Jul · Board meeting
May 2021
27 May · Board meeting
Apr 2021
6 Apr · Board meeting
Jan 2021
30 Jan · Board meeting
23 Jan · Board meeting